NCT01553721View on ClinicalTrials.gov

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

udenafil

"Phase IIa - Udenafil Dose 1, Dose 2(Single dose)~Phase IIb - Udenafil(BID)"

DRUG

placebo

Phase IIa - placebo Phase IIb - placebo

Trial Locations (9)

110-744

Seoul National University Hospital, Seoul

135-710

Samsung Medical Center, Seoul

120-752

Severance Hospital, Yonsei University Health System, Special City of Seoul

Unknown

Chungbook national University Hospital, Chungju

Chungnam National University Hospital, Daejeon

Chonnam National University Hospital, Gwangju

Pusan national University Hospital, Pusan

Asan Medical Center, Seoul

The catholic univ. of korea Seoul ST. MARY's hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT01553721 - Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) | Biotech Hunter | Biotech Hunter